M. Patricia Rivera was named associate director of Diversity, Equity, and Inclusion and director of the Clinical Lung Screening Program at Wilmot Cancer Institute at the University of Rochester Medical Center. Rivera also joined the Department of Medicine as division chief of Pulmonary and Critical Care Medicine.
The rapid acceleration of drug development has exponentially increased the therapeutic options available to patients with cancer.
On Feb. 23, two exciting cancer initiatives converged in San Antonio, Texas: the Biden Administration’s Cancer Moonshot, and the third Advancing the Science of Cancer in Latinos biennial conference.
A panel convened by the Cancer History Project for Black History Month started with a discussion of mentorship, and concluded with a big underlying concept—justice.
Edith Mitchell came a long way from growing up on a Tennessee farm, to becoming a brigadier general and serving on the President’s Cancer Panel.
In a 14:1 vote, ODAC nixes a PD-1 drug developed in China; data not generalizable to U.S. population
The FDA Oncologic Drugs Advisory Committee expressed decisive support for the agency’s view that data from trials of checkpoint inhibitors performed in mainland China aren’t applicable to the U.S. population.
Since COVID-19 made its way to the United States, we have seen a stream of worrying news of the pandemic’s impact on cancer care in the U.S., including 9.4 million missed screenings for just about all forms of cancer. While screening rates rebounded in the fall of 2020, there’s a growing concern from oncologists that screenings haven’t returned to pre-pandemic levels for everyone.
The Cancer History Project Guest Editor Robert Winn focused on the legacy of LaSalle Leffall, a Howard University surgical oncologist. He and John H. Stewart, director of Louisiana State University-Louisiana Children’s Medical Center Health Cancer Center spoke with Wayne A.I. Frederick, president of Howard University.
Racial and ethnic inequities are pervasive in clinical research—from the systemic factors that deter underrepresented populations from pursuing careers in science and medicine, to the discrimination, lack of support, and other hardships faced by those who do enter the biomedical profession.
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has announced three senior leadership appointments.
